(Australia-NewsWire.Com, April 05, 2018 ) Asia-Pacific Next Generation Sequencing (NGS) Market: By Type (Products (Instruments & Software, Consumables (Reagents & kits) and Services (Sequencing Services and Data Analysis Services)), By Technology (Whole Targeted Re-sequencing, Whole Genome Sequencing, Transcriptome (RNA-Seq), Whole Exome Sequencing, De Novo Sequencing, ChiP Sequencing, Methylation Sequencing, and Others), By Application (Diagnostics, Drug Discovery & Development, Biomarker Discovery, Agriculture & Animal Health Research, and Personalised Medicine) By End User (Academic Institutes & Research Centers, Hospital/Clinical Laboratories, Biotech/Pharmaceuticals Companies, and Others), and Country (Japan, China, India, Australia & New Zealand, ASEAN, South Korea, and Rest of Asia-Pacific) Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2024
Asia-Pacific Next Generation Sequencing (NGS) Market Report Description: Asia-Pacific Next Generation Sequencing (NGS) market report gives comprehensive outlook on Next Generation Sequencing (NGS) adoption pattern across the region with special emphasis on key countries such as Japan, China, India, Australia & New Zealand, Indonesia, Thailand, Vietnam, Philippines, Malaysia, and South Korea. The report on Next Generation Sequencing (NGS) market gives historical, current, and future market sizes (US$ Mn) on the basis of type, technology, application, end user, and country. This report presents Next Generation Sequencing (NGS) market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Next Generation Sequencing (NGS) market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Next Generation Sequencing (NGS) market to better equip clients with possible investment opportunities across the regions (Country Investment Hot-Spots) and market unmet needs. Key stakeholders of the Asia-Pacific Next Generation Sequencing (NGS) market report include raw material suppliers, manufacturers, marketers, policy makers, and healthcare service providers, who are engaged in usage and advocacy of Next Generation Sequencing (NGS) methods.
Asia-Pacific Next Generation Sequencing (NGS) Market: Asia-Pacific Next Generation Sequencing (NGS) market was valued around US$ 570 Mn in 2016 and poised to grow around 24.0% CAGR over 2017-2023.
Competition Assessment Key players profiles in the Asia-Pacific Next Generation Sequencing (NGS) market include: Agilent Technologies Inc. BGI (Beijing Genomics Institute) Biomatters Ltd. DNASTAR Inc. GATC Biotech Ag Genomatix Software GmbH Illumina Incorporated Knome Inc. Life Sciences (Roche) Macrogen Inc.
Oxford Nanopore Technologies Ltd. Pacific Biosciences Partek Inc. Perkin Elmer Inc. Qiagen N.V Thermo Fischer Scientific Players in the Asia-Pacific Next Generation Sequencing (NGS) market are entering into partnerships and collaborations to garner larger market share
Key Features of the Report: The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2024) The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market The report tracks recent innovations, key developments and startups details that are actively working in the market The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market
Detailed Segmentation By Type Products o Instruments & Software o Consumables (Reagents & kits) Services o Sequencing Services o Data Analysis Services By Technology Whole Targeted Re-sequencing Whole Genome Sequencing Transcriptome (RNA-Seq) Whole Exome Sequencing De Novo Sequencing ChiP Sequencing Methylation Sequencing Others By Application Diagnostics Drug Discovery & Development Biomarker Discovery Agriculture & Animal Health Research Personalised Medicine By End User Academic Institutes & Research Centers Hospital/Clinical Laboratories Biotech/Pharmaceuticals Companies Others Geography Asia-Pacific o Japan o China o India o Australia & New Zealand o ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others) o South Korea o Rest of Asia-Pacific
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBIs approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights